Bioregenx (BRGX) Total Liabilities (2021 - 2026)

Bioregenx has reported Total Liabilities for 6 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 20.51% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 20.51% YoY), and the FY2025 full-year result was $4.9 million, up 27.28% from the prior year.
• Total Liabilities for Q1 2026 stood at $4.9 million, down from $4.9 million in the prior quarter.
• The five-year high for Total Liabilities was $4.9 million in Q4 2025, with the low at $101553.0 in Q1 2022.
• Average Total Liabilities over 5 years is $2.5 million, with a median of $3.5 million recorded in 2024.
• Year-over-year, Total Liabilities gained 10.9% in 2023 and soared 1480.07% in 2024.
• Tracing BRGX's Total Liabilities over 5 years: stood at $260691.0 in 2022, then surged by 1026.69% to $2.9 million in 2023, then surged by 32.36% to $3.9 million in 2024, then advanced by 27.28% to $4.9 million in 2025, then retreated by 1.57% to $4.9 million in 2026.
• The last three Total Liabilities figures came in at $4.9 million (Q1 2026), $4.9 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.

Peer Comparison